HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survivalPratistha Koirala(Albert Einstein College of Medicine), Richard Görlick(Albert Einstein College of Medicine)Scientific ReportsAugust 17, 201610.1038/srep31154Cited by 106SaveCiteExport RISWatch citationsRelated PapersPlatelet‐derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma|Cancer|2008|114R1507, a fully human monoclonal antibody targeting IGF‐1R, is effective alone and in combination with rapamycin in inhibiting growth of osteosarcoma xenografts|Pediatric Blood & Cancer|2010|82